Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04569786
What this trial is testing

Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 232
Testing effectiveness (Phase 2)UnknownNCT02247362
What this trial is testing

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Who this might be right for
Influenza
VaxInnate Corporation 200
Early research (Phase 1)Active Not RecruitingNCT07289503
What this trial is testing

Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above

Who this might be right for
Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd. 96
Testing effectiveness (Phase 2)Ended earlyNCT01424501
What this trial is testing

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Who this might be right for
Tuberculosis
GlaxoSmithKline 142
Early research (Phase 1)Study completedNCT05724472
What this trial is testing

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

Who this might be right for
Ebola Sudan Virus Disease
International AIDS Vaccine Initiative 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06838195
What this trial is testing

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Who this might be right for
DysenteryDysentery, Shigella
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Post-approval studies (Phase 4)UnknownNCT05105295
What this trial is testing

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected

Who this might be right for
COVID-19HIV Infections
China National Biotec Group Company Limited 400
Large-scale testing (Phase 3)Study completedNCT03439657
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 913
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Testing effectiveness (Phase 2)Study completedNCT00778895
What this trial is testing

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

Who this might be right for
Influenza
GlaxoSmithKline 390
Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)WithdrawnNCT03265977
What this trial is testing

A Phase II Study of H56:IC31 in Healthy Adolescents

Who this might be right for
Tuberculosis Infection
Aeras
Large-scale testing (Phase 3)Study completedNCT00877877
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 632
Testing effectiveness (Phase 2)Study completedNCT00896064
What this trial is testing

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 43
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Large-scale testing (Phase 3)Study completedNCT00808392
What this trial is testing

Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Who this might be right for
Haemophilus Influenzae Type b
Novartis Vaccines 916
Early research (Phase 1)Study completedNCT00374998
What this trial is testing

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 35
Early research (Phase 1)Study completedNCT04238663
What this trial is testing

Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers

Who this might be right for
Healthy Volunteers
mAbxience Research S.L. 115
Early research (Phase 1)Study completedNCT03080987
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation